5.0
8 May 2024
Current employee
Recommend
CEO approval
Business outlook
Pros
Good teams of people, ability to interact with cross functional groups within company and make an impact if you do good work.
Cons
Company is in a weird phase transitioning from pre-clinical R&D to potential commercial company. Lack of clarity and consistency on what is required for certain titles and some people do more work than people “above” them in terms of titles despite similar backgrounds and experience. Too much focus on DE&I and committees and not the science.